|
|
Volumn 8, Issue 5, 2002, Pages 674-679
|
|
Cost related to replacement therapy during hospitalization in haemophiliacs with or without inhibitors: Experience of six French haemophilia centres
a,g
|
|
Author keywords
Clotting factors; Costs; Haemophilia; Inhibitors
|
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
BLOOD CLOTTING FACTOR 8 CONCENTRATE;
BLOOD CLOTTING FACTOR 8 INHIBITOR;
BLOOD CLOTTING FACTOR 9 CONCENTRATE;
BLOOD CLOTTING FACTOR 9 INHIBITOR;
BLOOD CLOTTING INHIBITOR;
LFB;
PROTHROMBIN COMPLEX;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLEEDING;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE SEVERITY;
DRUG COST;
EXPERIENCE;
FRANCE;
HEALTH CARE COST;
HEALTH CENTER;
HEALTH ECONOMICS;
HEMOPHILIA A;
HEMOPHILIA B;
HOSPITAL MANAGEMENT;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RESOURCE MANAGEMENT;
SUBSTITUTION THERAPY;
SURGICAL TECHNIQUE;
|
|
EID: 0036736443
PISSN: 13518216
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2516.2002.00671.x Document Type: Article |
|
Times cited : (16)
|
|
References (8)
|
